Abstract
We report the case of a woman who first received MgSO(4) for eclampsia prophylaxis and then was treated with MgSO(4) for eclampsia. She developed hyperkalemia without severe renal failure or another explanation. We recommend close monitoring, including serial measurements of electrolytes, when MgSO(4) is administered for eclampsia prophylaxis or treatment.
MeSH terms
-
Adult
-
Anticonvulsants / adverse effects*
-
Eclampsia / drug therapy
-
Eclampsia / pathology
-
Female
-
Humans
-
Hyperkalemia / chemically induced*
-
Magnesium Sulfate / adverse effects*
-
Postpartum Period
-
Pregnancy
-
Pregnancy Trimester, Third
-
Puerperal Disorders / chemically induced*
-
Renal Insufficiency / chemically induced*
Substances
-
Anticonvulsants
-
Magnesium Sulfate